Cargando…
Anemia and heart failure: a cause of progression or only a consequence?
Anemia is one of the most frequent co-morbidities in the patients with heart failure. Its prevalence increases from 4–7% in the subjects with asymptomatic left ventricular dysfunction to >30% in the patients with severe heart failure. Renal insufficiency, activation of inflammatory mediators, and...
Autores principales: | METRA, MARCO, NODARI, SAVINA, BORDONALI, TANIA, BUGATTI, SILVIA, FONTANELLA, BENEDETTA, LOMBARDI, CARLO, SAPORETTI, ALBERTO, VERZURA, GIULIA, DANESI, ROSSELLA, DEI CAS, LIVIO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184679/ https://www.ncbi.nlm.nih.gov/pubmed/21977269 http://dx.doi.org/10.4081/hi.2007.1 |
Ejemplares similares
-
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
por: Metra, Marco, et al.
Publicado: (2007) -
The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
por: NODARI, SAVINA, et al.
Publicado: (2007) -
Non-compaction of the ventricular myocardium
por: VIZZARDI, ENRICO, et al.
Publicado: (2006) -
Endocannabinoids and cardiovascular prevention: real progress?
por: NODARI, SAVINA, et al.
Publicado: (2007) -
Endothelial damage due to air pollution
por: NODARI, SAVINA, et al.
Publicado: (2006)